Bajaj Finserv Healthcare Fund
Bajaj Finserv Mutual Fund · FM: Siddharth Chaudhary, Vinay Bafna, Bharat Hegde · INF0QA701AB9 · Direct
NAV ₹12.21 AUM ₹354 Cr as of 22 Sep 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:29 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.9% | +0.8% | +10.7% | +31.1% | +22.1% | — | — | 11/234 | 0.90% |
Equity allocation
96.15%
Non-equity allocation (combined)
3.85%
All Equity Holdings (33) latest available
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Divi's Laboratories Ltd | 29.8 | 8.40% | — |
| 2 | Apollo Hospitals Enterprise Ltd | 23.8 | 6.71% | — |
| 3 | Aurobindo Pharma Ltd | 23.1 | 6.52% | — |
| 4 | Sun Pharmaceuticals Industries Ltd | 22.5 | 6.36% | — |
| 5 | Piramal Pharma Ltd | 21.4 | 6.04% | — |
| 6 | Rubicon Research Ltd | 21.3 | 6.02% | — |
| 7 | Torrent Pharmaceuticals Ltd | 18.6 | 5.26% | — |
| 8 | Neuland Laboratories Ltd | 16.2 | 4.59% | — |
| 9 | Emcure Pharmaceuticals Ltd | 15.4 | 4.36% | — |
| 10 | Max Healthcare Institute Ltd Ordinary Shares | 14.7 | 4.16% | — |
| 11 | Fortis Healthcare Ltd | 11.5 | 3.25% | — |
| 12 | Zydus Wellness Ltd | 10.0 | 2.82% | — |
| 13 | Ipca Laboratories Ltd | 8.6 | 2.43% | — |
| 14 | Vijaya Diagnostic Centre Ltd | 8.3 | 2.36% | — |
| 15 | Senores Pharmaceuticals Ltd | 8.1 | 2.29% | — |
| 16 | Navin Fluorine International Ltd | 7.7 | 2.17% | — |
| 17 | Laurus Labs Ltd | 7.6 | 2.14% | — |
| 18 | Shaily Engineering Plastics Ltd | 7.2 | 2.03% | — |
| 19 | Sanofi Consumer Healthcare India Ltd | 6.4 | 1.80% | — |
| 20 | Glenmark Pharmaceuticals Ltd | 6.1 | 1.73% | — |
| 21 | GlaxoSmithKline Pharmaceuticals Ltd | 5.8 | 1.65% | — |
| 22 | Dr. Lal PathLabs Ltd | 5.8 | 1.64% | — |
| 23 | Zydus Lifesciences Ltd | 5.0 | 1.40% | — |
| 24 | Biocon Ltd | 4.8 | 1.35% | — |
| 25 | Abbott India Ltd | 4.4 | 1.25% | — |
| 26 | Medplus Health Services Ltd | 4.2 | 1.18% | — |
| 27 | Krishna Institute of Medical Sciences Ltd | 4.1 | 1.15% | — |
| 28 | Medi Assist Healthcare Services Ltd | 3.7 | 1.04% | — |
| 29 | Eris Lifesciences Ltd Registered Shs | 3.6 | 1.01% | — |
| 30 | Turtlemint Fintech Solutions Ltd | 3.5 | 1.00% | — |
| 31 | Jubilant Pharmova Ltd | 3.4 | 0.96% | — |
| 32 | AstraZeneca Pharma India Ltd | 2.7 | 0.76% | — |
| 33 | MTAR Technologies Ltd | 1.1 | 0.32% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.